The U.S. Food and drug Administration (FDA)’s Center for Veterinary Medicine has issued a request for information (RFI) seeking public input, particularly from veterinarians, on the use of cannabis-derived products (CDPs) in animals. The focus is on cannabidiol (CBD) and hemp-derived products, with the agency gathering insights on usage trends, quality standards, benefits, drug interactions, safety concerns, and toxicology. Feedback from this RFI will help the FDA better understand potential safety issues and veterinarians’ experiences with these products. The Federal Register notice provides submission instructions, and anonymous comments are welcome. The comment period runs from January 16 to April 16, 2025.
